Join to View Full Profile
1400 VFW ParkwayBoston, MA 02132
Dr. Gupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kalpana Gupta is an infectious disease specialist based in Boston, MA, with extensive experience in urinary tract infections. She completed her medical education at the Stony Brook University Health Sciences Center School of Medicine in 1991 and pursued residency and fellowship training at Beth Israel Deaconess Medical Center and the University of Washington. Dr. Gupta has contributed to the field through various publications, including studies on urinary tract infections, healthcare worker attitudes towards preoperative urine cultures, and sickness presenteeism during the COVID-19 pandemic. She is involved in clinical trials, such as one focusing on the optimal treatment for recurrent Clostridium difficile infections.
Education & Training
University of WashingtonFellowship, Infectious Disease, 1996 - 2000
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1995 - 1996- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1994
Stony Brook University Health Sciences Center School of MedicineClass of 1991
Certifications & Licensure
CT State Medical License 2003 - 2026
American Board of Internal Medicine Infectious Disease
Clinical Trials
- Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Roles: Contact
Publications & Presentations
PubMed
- Impact of low-amplitude pulse interspersed with histotripsy treatment of Staphylococcus aureus biofilms on surgical mesh.Timothy A Bigelow, Andrew C Petersen, Dingiswayo A Chikhwaza, Huaiqing Wu, Hongbo Yu
Ultrasonics. 2025-12-01 - Acceptability of proposed stewardship interventions to reduce preoperative screening and treatment of asymptomatic bacteriuria.Kimberly C Dukes, Kalpana Gupta, Julia Friberg Walhof, Madisen E Brown, Judith Strymish
American Journal of Infection Control. 2025-11-01 - Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir.Kalpana Gupta, William J O'Brien, Judith Strymish, Anna Chen, Katherine Linsenmeyer
Infectious Disease Reports. 2025-05-01
Other
- Acute uncomplicated cystitis and pyelonephritis in womenGupta K, Hooton TM
http://www.uptodate.com/contents/acute-uncomplicated-cystitis-and-pyelonephritis-in-women
UpToDate, Wolters Kluwer Health - 2012-12-06 - Recurrent urinary tract infection in womenGupta K, Hooton TM
http://www.uptodate.com/contents/recurrent-urinary-tract-infection-in-women
UpToDate, Wolters Kluwer Health - 2013-03-07 - Urinary tract infections and asymptomatic bacteriuria in pregnancyGupta K, Hooton TM
http://www.uptodate.com/contents/urinary-tract-infections-and-asymptomatic-bacteriuria-in-pregnancy
UpToDate, Wolters Kluwer Health - 2012-09-20
Press Mentions
Why UTIs Are Getting so Much Harder to TreatJune 6th, 2025- Pfizer Dominates the COVID Drug Market. This Watertown Biotech Wants to Change ThatNovember 9th, 2022
- Boston Infectious Disease Specialists: Our New Year’s ResolutionsDecember 31st, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
